XML 14 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Income - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Feb. 28, 2017
Feb. 29, 2016
Feb. 28, 2017
Feb. 29, 2016
Revenues        
Product revenues $ 73,964 $ 64,377 $ 223,170 $ 198,131
Service revenues 14,421 12,348 39,577 33,065
Total Revenues 88,385 76,725 262,747 231,196
Cost of Revenues        
Cost of product revenues 38,816 32,920 113,241 97,558
Cost of service revenues 8,689 8,609 24,556 22,427
Total Cost of Revenues 47,505 41,529 137,797 119,985
Gross Margin 40,880 35,196 124,950 111,211
Operating Expenses        
Sales and marketing 15,340 13,953 45,824 41,727
General and administrative 8,548 7,538 25,094 21,081
Research and development 2,641 2,451 8,087 7,642
Total Operating Expenses 26,529 23,942 79,005 70,450
Operating Income 14,351 11,254 45,945 40,761
Other Income (Expense)        
Interest income 271 120 690 238
Other income (expense) 1,105 265 1,098 (730)
Total Other Income (Expense) 1,376 385 1,788 (492)
Income Before Taxes 15,727 11,639 47,733 40,269
Provision for Income Taxes 5,350 3,350 16,250 13,550
Net Income 10,377 8,289 31,483 26,719
Net (Income) Loss Attributable to Non-Controlling Interest (90) 22 (163) (12)
Net Income Attributable to Neogen $ 10,287 $ 8,311 $ 31,320 $ 26,707
Net Income Attributable to Neogen Per Share        
Basic $ 0.27 $ 0.22 $ 0.83 $ 0.71
Diluted $ 0.27 $ 0.22 $ 0.82 $ 0.71